Peficitinib(CAS 944118-01-8) is a novel potent JAK inhibitor, which demonstrated potent efficacy in adjuvant-induced arthritis model in rats.
This report contains market size and forecasts of Peficitinib in global, including the following market information:
Global Peficitinib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Peficitinib Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Peficitinib companies in 2021 (%)
The global Peficitinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peficitinib include Cayman Chemical, Adooq Bioscience, BioVision, Biorbyt, MyBiosource, AbMole, Taiclone, Selleck Chemicals and BOC Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peficitinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peficitinib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Peficitinib Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Peficitinib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Peficitinib Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Peficitinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Peficitinib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peficitinib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Peficitinib revenues share in global market, 2021 (%)
Key companies Peficitinib sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Peficitinib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cayman Chemical
Adooq Bioscience
BioVision
Biorbyt
MyBiosource
AbMole
Taiclone
Selleck Chemicals
BOC Sciences
Wuhan Sun-shine Bio-technology
MedKoo Biosciences